News & Articles

Results per page

25

Selected Filters:

Novo Nordisk A/S Clear Filters

Industry News

Improved Glycaemic Control for People with Diabetes

Clinical study results suggest individuals with type I or II diabetes may achieve improved glycaemic control with Tresiba

3 Oct 2018

Product News

Ryzodeg® Offers Simpler Solution with Once-Daily Dosing and Reduced Risk of Nocturnal Hypoglycaemia vs Insulin

3 Oct 2018

Product News

Ozempic Reduces Risk of Major Cardiovascular Events Across Type 2 Diabetes Populations at High CV Risk

2 Sept 2018

Product News

Ryzodeg Shown to Significantly Reduce the Risk of Low Blood Sugar in People with Type 2 Diabetes Who Fast During Ramadan

12 Dec 2017

Industry News

Participants Report Xultophy a Better Option than Basal-Bolus Insulin Therapy in DUAL VII Clinical Trial on Managing Type 2 Diabetes

8 Dec 2017

Product News

FDA Approves TRETTEN® for the Treatment of Congenital Factor XIII A-Subunit Deficiency

8 Jan 2014

Novo Nordisk A/S | Articles